Fingolimod effect on brain volume loss independently contributes to its effect on disability
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Fingolimod effect on brain volume loss independently contributes to its effect on disability
Authors
Keywords
-
Journal
Multiple Sclerosis Journal
Volume 21, Issue 7, Pages 916-924
Publisher
SAGE Publications
Online
2015-02-07
DOI
10.1177/1352458515569099
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical Relevance of Brain Volume Measures in Multiple Sclerosis
- (2014) Nicola De Stefano et al. CNS DRUGS
- Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial
- (2014) Peter A Calabresi et al. LANCET NEUROLOGY
- Treatment effect on brain atrophy correlates with treatment effect on disability in multiple sclerosis
- (2013) Maria Pia Sormani et al. ANNALS OF NEUROLOGY
- MRI lesions as a surrogate for relapses in multiple sclerosis: a meta-analysis of randomised trials
- (2013) Maria Pia Sormani et al. LANCET NEUROLOGY
- Combined MRI lesions and relapses as a surrogate for disability in multiple sclerosis
- (2011) M. P. Sormani et al. NEUROLOGY
- Magnetic resonance active lesions as individual-level surrogate for relapses in multiple sclerosis
- (2010) Maria Pia Sormani et al. Multiple Sclerosis Journal
- Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes
- (2010) N. De Stefano et al. NEUROLOGY
- A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
- (2010) Ludwig Kappos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
- (2010) Jeffrey A. Cohen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Magnetic resonance imaging as a potential surrogate for relapses in multiple sclerosis: A meta-analytic approach
- (2009) Maria Pia Sormani et al. ANNALS OF NEUROLOGY
- Cortical Lesions and Atrophy Associated With Cognitive Impairment in Relapsing-Remitting Multiple Sclerosis
- (2009) Massimiliano Calabrese et al. ARCHIVES OF NEUROLOGY
- FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system
- (2009) Volker Brinkmann BRITISH JOURNAL OF PHARMACOLOGY
- A voxel-based morphometry study of disease severity correlates in relapsing— remitting multiple sclerosis
- (2009) A. Prinster et al. Multiple Sclerosis Journal
- Imaging outcomes for neuroprotection and repair in multiple sclerosis trials
- (2009) Frederik Barkhof et al. Nature Reviews Neurology
- Gray matter atrophy in multiple sclerosis: A longitudinal study
- (2008) Elizabeth Fisher et al. ANNALS OF NEUROLOGY
- Brain Volume Decline in Aging
- (2008) Anthony F. Fotenos et al. ARCHIVES OF NEUROLOGY
- Brain Atrophy Assessment in Multiple Sclerosis: Importance and Limitations
- (2008) Antonio Giorgio et al. NEUROIMAGING CLINICS OF NORTH AMERICA
- Predicting short-term disability progression in early multiple sclerosis: added value of MRI parameters
- (2007) A Minneboo et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started